TTK Healthcare (NSE:TTKHLTCARE) EV-to-EBIT : 13.70 (As of May. 23, 2024)

View and export this data going back to 2010. Start your Free Trial

What is TTK Healthcare EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, TTK Healthcare's Enterprise Value is ₹12,255 Mil. TTK Healthcare's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₹894 Mil. Therefore, TTK Healthcare's EV-to-EBIT for today is 13.70.

The historical rank and industry rank for TTK Healthcare's EV-to-EBIT or its related term are showing as below:

NSE:TTKHLTCARE' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.98 Med: 21.51 Max: 63.71
Current: 13.71

During the past 13 years, the highest EV-to-EBIT of TTK Healthcare was 63.71. The lowest was 7.98. And the median was 21.51.

NSE:TTKHLTCARE's EV-to-EBIT is ranked better than
61.52% of 673 companies
in the Drug Manufacturers industry
Industry Median: 17.18 vs NSE:TTKHLTCARE: 13.71

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. TTK Healthcare's Enterprise Value for the quarter that ended in Dec. 2023 was ₹20,028 Mil. TTK Healthcare's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₹894 Mil. TTK Healthcare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 4.47%.

TTK Healthcare EV-to-EBIT Historical Data

The historical data trend for TTK Healthcare's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TTK Healthcare EV-to-EBIT Chart

TTK Healthcare Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-EBIT

Get a 7-Day Free Trial

20.29

15.96

20.17

32.80

9.60

TTK Healthcare Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															30.87	9.60	22.60	9.03	22.27

Competitive Comparison of TTK Healthcare's EV-to-EBIT

For the Drug Manufacturers - General subindustry, TTK Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TTK Healthcare's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TTK Healthcare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where TTK Healthcare's EV-to-EBIT falls into.

TTK Healthcare EV-to-EBIT Calculation

TTK Healthcare's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	12254.654	/	894.29
	=	13.70

TTK Healthcare's current Enterprise Value is ₹12,255 Mil.
TTK Healthcare's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹894 Mil.

TTK Healthcare (NSE:TTKHLTCARE) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

TTK Healthcare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	894.29	/	20027.580705
	=	4.47 %

TTK Healthcare's Enterprise Value for the quarter that ended in Dec. 2023 was ₹20,028 Mil.
TTK Healthcare's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹894 Mil.

TTK Healthcare EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of TTK Healthcare's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

TTK Healthcare (NSE:TTKHLTCARE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TTK Healthcare Ltd (NSE:TTKHLTCARE) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

507747:India

Address

No. 6, Cathedral Road, Chennai, TN, IND, 600 086

Website

https://www.ttkhealthcare.com

TTK Healthcare Ltd is an Indian pharmaceutical company. The company's operating segment includes Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods Division, and Others. Its Animal Welfare segment includes products for both Human and Veterinary use. The Consumer Products comprises of marketing and distribution of Woodwards's Gripe Water, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners and others. Protective Devices comprises of manufacturing and marketing of Male Contraceptives and other allied products. It generates maximum revenue from the Pharmaceuticals segment. Geographically, it derives a majority of revenue from India.

TTK Healthcare (NSE:TTKHLTCARE) Headlines

No Headlines